Insights Into Breast Cancer 2025

Insights into current treatment approaches for HR+, HER2+, and triple-negative breast cancer.

Northeast August 22, 2025
Purchase Report

FACULTY CHAIR

Joshua Drago, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

MORE INFORMATION

  • New York
  • New Jersey
  • Maryland
  • Pennsylvania

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • Gain perspectives of current treatment practices and recent updates in
    • Triple-negative breast cancer
    • HER2+ metastatic breast cancer
    • HR+ early breast cancer and metastatic breast cancer

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and moderated discussion.
  • The group of advisors comprises 12 community oncologists from the Northeast region of the United States.

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.